For the quarter ending 2026-03-31, CL had $47M increase in cash & cash equivalents over the period. $609M in free cash flow.
| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Net income including noncontrolling interests | 681 | -5 | 767 | 773 |
| Depreciation and amortization | 156 | 173 | 158 | 151 |
| Erisa litigation matter | 0 | 0 | 0 | 0 |
| Restructuring and termination benefits, net of cash | 165 | 8 | -2 | -6 |
| Stock-based compensation expense | 40 | 28 | 72 | 32 |
| Goodwill and intangible assets impairment charges | - | 919 | - | - |
| Deferred income taxes | -18 | -117 | 25 | 7 |
| Receivables | 215 | -164 | 28 | -22 |
| Inventories | 41 | -100 | -6 | -89 |
| Accounts payable and other working capital | -11 | 251 | - | - |
| Accounts payable and other accruals | - | - | 278 | -191 |
| Other non-current liabilities | -19 | -35 | - | - |
| Other non-current assets and liabilities | - | - | 15 | -7 |
| Other non-current assets | -29 | -95 | - | - |
| Net cash provided by (used in) operations | 747 | 1,453 | 1,261 | 884 |
| Capital expenditures | 138 | 177 | 155 | 108 |
| Purchases of marketable securities and investments | 70 | 161 | 153 | 250 |
| Proceeds from sale of marketable securities and investments | 94 | 244 | 158 | 253 |
| Payment for acquisition, net of cash acquired | - | - | 293 | - |
| Payment for acquisitions, net of cash acquired | - | 0 | - | 293 |
| Other investing activities | 8 | 9 | 4 | 3 |
| Net cash provided by (used in) investing activities | -122 | -103 | -154 | -401 |
| Short-term borrowing (repayment) less than 90 days, net | 1,138 | -1,128 | 169 | -194 |
| Principal payments of debt | 1,082 | 0 | 516 | 135 |
| Proceeds from issuance of debt | - | 691 | 0 | 497 |
| Dividends paid | 417 | 523 | 420 | 474 |
| Purchases of treasury shares | 306 | 406 | 288 | 232 |
| Proceeds from exercise of stock options | 127 | 18 | 18 | 25 |
| Other financing activities | -23 | -13 | 9 | 104 |
| Net cash provided by (used in) financing activities | -563 | -1,361 | -1,028 | -409 |
| Effect of exchange rate changes on cash and cash equivalents | -15 | 20 | -15 | 29 |
| Net increase (decrease) in cash and cash equivalents | 47 | 9 | 64 | 103 |
| Cash and cash equivalents at beginning of the period | 1,288 | 1,279 | 1,215 | 1,112 |
| Cash and cash equivalents at end of the period | 1,335 | 1,288 | 1,279 | 1,215 |
COLGATE PALMOLIVE CO (CL)
COLGATE PALMOLIVE CO (CL)